e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Cystic fibrosis: basic and applied science
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Defective A20 signalling in CF: Anti-inflammatory action of gibberellins
C. Kelly, J. Reihill, B. Malconsom, A. Czerwiec, B. Hirsch, S. Elborn, M. Ennis, B. Schock (Keele, Belfast, United Kingdom; Berlin, Germany)
Source:
Annual Congress 2013 –Cystic fibrosis: basic and applied science
Session:
Cystic fibrosis: basic and applied science
Session type:
Poster Discussion
Number:
2106
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Kelly, J. Reihill, B. Malconsom, A. Czerwiec, B. Hirsch, S. Elborn, M. Ennis, B. Schock (Keele, Belfast, United Kingdom; Berlin, Germany). Defective A20 signalling in CF: Anti-inflammatory action of gibberellins. Eur Respir J 2013; 42: Suppl. 57, 2106
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Cystic fibrosis and intestinal organoids
Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Novel therapeutics for cystic fibrosis
Related content which might interest you:
Anti-inflammatory action of Gibberellin in lung epithelial cells is mediated by modification of NF-κB related kinase expression
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014
MiR-31 regulates IRF-1 function in cystic fibrosis epithelial cells
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
Regulation of interleukin-8 by miR-17 during chronic inflammation in cystic fibrosis
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015
microRNA-mediated inhibition of IL-8 production from cystic fibrosis bronchial epithelial cells
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
Identification of novel proteins involved in beta-catenin dependent alveolar epithelial trans-differentiation
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Impact of Wnt ligand secretion on cellular phenotypes in pulmonary fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Metformin inhibits TGF-b-induced myofibroblast differentiation through AMPK activation
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Airway epithelial cell IP-10 production is regulated by miR-31 via the transcription factor IRF-1
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
K
Ca
3.1 mediates alphaSMA expression in human lung myofibroblast via the Smad2/3 and TGFbeta1 signalling pathway
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Inhibitors of apoptosis proteins in asthmatic airway inflammation
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
CFTR-dependent deficiency in alternatively-activated macrophages in cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Novel antiviral properties of vitamin D in cystic fibrosis airway epithelial cells
Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Year: 2014
Altered protein homeostasis in pulmonary fibrosis indicates a role for proteasomal activator 200
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Epithelial cell regulation of immunity in cystic fibrosis
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research
Year: 2012
Induced pluripotent stem cells conditioned media (iPS-cm) modulates macrophage phenotype in the fibrotic lung
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
LATE-BREAKING ABSTRACT: Reducing inflammation in the lung by targeting the endothelial cystic fibrosis transmembrane conductance regulator with copper-tobramycin
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
TNF-a induces cPLA
2
expression via Jak2/PDGFR-dependent Elk-1/p300 activation in human lung epithelial cells
Source: International Congress 2014 – Mechanistic studies of the airway epithelium
Year: 2014
Gene expression changes of Wnt signalling components during alveolar epithelial transdifferentiation
Source: International Congress 2014 – Acute lung injury: hitting the barriers
Year: 2014
Regulation of WISP1 by profibrotic cytokines in pulmonary fibrosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept